Pacific Shuanglin Bio-Pharmacy (000403.SZ) announced that the company will implement the mid-term profit distribution for 2024, with every 10 shares...
According to the Zhixin Finance APP, Pacific Shuanglin Bio-Pharmacy (000403.SZ) announced that the company will implement the mid-term profit distribution for 2024, distributing 1.5 yuan for every 10 shares, with the equity registration date on December 16th.